This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Dr Qiuheng Jin
Chief Scientific Officer & R&D Director, Biopharma Division at Vazyme Biotech Co., Ltd
Speaker

Profile

Dr. Jin specializes in atomic-level structural analysis of membrane proteins and the molecular mechanisms of transmembrane transport. He has over a decade of R&D and applied experience in nucleic-acid therapeutics, with core research interests in mRNA therapeutics, oligonucleotide drugs, and gene-editing technologies. Dr. Jin has led multiple key projects spanning basic research to product development, authored numerous high-impact peer-reviewed publications, and has filed and been granted several important patents.

Agenda Sessions

  • A Novel Ligase for Modified Oligonucleotide Synthesis

    10:35am